Results 41 to 50 of about 194,150 (247)
Final oocyte maturation in GnRH antagonist co-treated IVF/ICSI cycles can be triggered with HCG or a GnRH agonist. We conducted a systematic review and meta-analysis of randomized controlled trials to evaluate the efficacy and safety of the final oocyte ...
M.A.F. Youssef +3 more
doaj +1 more source
Objective: To examine whether the Stop GnRH-agonist combined with multiple-dose GnRH-antagonist protocol may improve conventional IVF/intracytoplasmic sperm injection (ICSI) cycle in poor ovarian response (POR) patients.Design: Cohort historical, proof ...
Raoul Orvieto +7 more
doaj +1 more source
Background: Currently, there is some evidence that adenomyosis patients using gonadotropin-releasing hormone (GnRH) agonist long downregulation (LDR) prior to embryo transfer may improve in vitro fertilization (IVF) success rate, but not to the baseline ...
James Henshaw, Kelton Tremellen
doaj +1 more source
Abstract Objective To examine the effect of controlled ovarian stimulation (COS) protocol on follicular synchrony in a subsequent in vitro fertilization (IVF) cycle in patients whose previous cycle was canceled due to asynchrony. Methods A single‐center retrospective‐cohort study (January 2018–March 2024), including women undergoing IVF who had: (1) a ...
Alyssa Hochberg +5 more
wiley +1 more source
Severe OHSS rate of GnRH long agonist protocol versus GnRH antagonist protocol per woman.
Severe OHSS rate of GnRH long agonist protocol versus GnRH antagonist protocol per woman.
Lin Li (28817) +5 more
core +1 more source
Abstract Objective Heavy menstrual bleeding is one of the most common gynecologic disorders among women of reproductive age and has a significant impact on their physical, psychological, and social well‐being. Although international guidelines recommend medical therapy as the first‐line treatment, it may prove ineffective, poorly tolerated, or ...
Jonas Rudaitis +3 more
wiley +1 more source
Abstract Lynch syndrome and BRCA‐mutation associated malignancies are fortunately rare. Affected patients have an increased risk of cancer diagnosis at a young age, often significantly overlapping with their reproductive years. In helping these patients, oncologists must navigate the following areas of care: cancer prevention, impact of cancer ...
Anna Weimer +20 more
wiley +1 more source
The contribution of His7.36(305) of the GnRH receptor to ligand binding and receptor activation [PDF]
Bibliography: leaves 88-104.The current study was perfonned to give insights into the role of individual amino acid residues of both the GnRH receptor and the GnRH ligand in receptor function.
Mayevu, Ntateko Merriam Immogen
core +1 more source
Objective: To evaluate the effect of gonadotropin-releasing hormone (GnRH) agonist, administered in the luteal phase, on intracytoplasmic sperm injection (ICSI) outcome.
Dehghani Firouzabadi Razieh +2 more
doaj +1 more source
Comparison of results of controlled ovarian stimulation (initiated cycles) for patients with AMH
Ming-Chao Huang (798716) +6 more
core +1 more source

